Respiratory

Feature Article

Could a New Universal Tuberculosis Regimen Help End the TB Pandemic?

Could a New Universal Tuberculosis Regimen Help End the TB Pandemic?

The Lancet Respiratory Medicine staged a debate between proponents and opponents of pan-TB regimens to tackle the current suboptimal worldwide management of TB resistance.

Latest News

Increase in VA Legionnaires' Disease Rates From 2014 to 2016

Increase in VA Legionnaires' Disease Rates From 2014 to 2016

There was an increase in Legionnaires' Disease (LD) from 2014 to 2016.

Mandatory Influenza Vaccination Advised for Healthcare Personnel in VA, Non-VA Hospitals

Mandatory Influenza Vaccination Advised for Healthcare Personnel in VA, Non-VA Hospitals

A national survey was conducted to assess influenza prevention practices in Veterans Affairs and non-Veterans Affairs hospitals in the United States.

Improving Type-Based Surveillance of Enterovirus and Parechovirus

Improving Type-Based Surveillance of Enterovirus and Parechovirus

Between 2014 and 2016, a total of 2967 cases of enterovirus and parechovirus were reported to the National Enterovirus Surveillance System in the United States.

CDC: Invasive MRSA More Likely Among Injection Drug Users

CDC: Invasive MRSA More Likely Among Injection Drug Users

Injection drug users are more than 16-fold more likely to develop invasive methicillin-resistant Staphylococcus aureus infections.

PCV13 Reduces Hospitalization for Vaccine-Type Community-Acquired Pneumonia

PCV13 Reduces Hospitalization for Vaccine-Type Community-Acquired Pneumonia

The real-world effectiveness of PCV13 vaccine in preventing hospitalization for vaccine-type community-acquired pneumonia was assessed.

Respiratory Pathogens May Increase Asthma Treatment Failure Risk

Respiratory Pathogens May Increase Asthma Treatment Failure Risk

Respiratory pathogens are associated with increased risk of treatment failure in children with asthma exacerbations.

FDA Issues Final Guidance on Inhalational Anthrax

FDA Issues Final Guidance on Inhalational Anthrax

The FDA has issued final guidance to assist in the development of drugs for the prevention of inhalational anthrax.

Independent Predictors of Bronchiolitis Mortality After ED Discharge

Independent Predictors of Bronchiolitis Mortality After ED Discharge

Infants with bronchiolitis and comorbidities plus other predictive factors are at higher risk for death following discharge from the emergency department.

Early Clinical Response With Omadacycline vs Moxifloxacin in CABP

Early Clinical Response With Omadacycline vs Moxifloxacin in CABP

Early clinical response rates were similar across PORT risk class subgroups in patients with community-acquired bacterial pneumonia when treated with omadacycline or moxifloxacin.

Prior Atypical Antipsychotic Use May Increase Mortality Risk in Pneumonia

Prior Atypical Antipsychotic Use May Increase Mortality Risk in Pneumonia

Clinicians should consider these findings when using atypical antipsychotics in patients at risk for pneumonia.

Sign Up for Free e-newsletters